Legis Daily

Quit Because of COVID-19 Act

USA116th CongressHR-7286| House 
| Updated: 6/22/2020
Lisa Blunt Rochester

Lisa Blunt Rochester

Democratic Representative

Delaware

Cosponsors (41)
Kim Schrier (Democratic)Gilbert Ray Cisneros (Democratic)Stephanie N. Murphy (Democratic)Karen Bass (Democratic)Peter T. King (Republican)Darren Soto (Democratic)Derek Kilmer (Democratic)Eliot L. Engel (Democratic)Bobby L. Rush (Democratic)Steve Cohen (Democratic)Tony Cárdenas (Democratic)Paul Tonko (Democratic)Angie Craig (Democratic)Thomas R. Suozzi (Democratic)Wm. Lacy Clay (Democratic)Anthony G. Brown (Democratic)Lucille Roybal-Allard (Democratic)A. Donald McEachin (Democratic)Ann M. Kuster (Democratic)Joaquin Castro (Democratic)Mark DeSaulnier (Democratic)Harley Rouda (Democratic)Jahana Hayes (Democratic)Eleanor Holmes Norton (Democratic)Jamie Raskin (Democratic)Joe Neguse (Democratic)Diana DeGette (Democratic)Nydia M. Velázquez (Democratic)Yvette D. Clarke (Democratic)Brian K. Fitzpatrick (Republican)Bennie G. Thompson (Democratic)TJ Cox (Democratic)Nanette Diaz Barragán (Democratic)Donna E. Shalala (Democratic)Ayanna Pressley (Democratic)Alcee L. Hastings (Democratic)Debbie Wasserman Schultz (Democratic)Lauren Underwood (Democratic)Grace F. Napolitano (Democratic)Susan Wild (Democratic)Judy Chu (Democratic)

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Quit Because of COVID-19 Act This bill provides for Medicaid and Children's Health Insurance Program (CHIP) coverage of certain tobacco cessation services during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019), as well as for two years after the emergency period ends. Specifically, the bill provides for coverage of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines. The bill excludes such items and services from cost-sharing and applies an enhanced Federal Medical Assistance Percentage (i.e., federal matching rate).
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 22, 2020
Introduced in House
Jun 22, 2020
Referred to the House Committee on Energy and Commerce.
Aug 12, 2020

Latest Companion Bill Action

S 116-4524
Introduced in Senate
  • June 22, 2020
    Introduced in House


  • June 22, 2020
    Referred to the House Committee on Energy and Commerce.


  • August 12, 2020

    Latest Companion Bill Action

    S 116-4524
    Introduced in Senate

Health

Related Bills

  • S 116-4524: Quit Because of COVID–19 Act
Cardiovascular and respiratory healthChild healthDrug, alcohol, tobacco useDrug therapyEmergency medical services and trauma careHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive careInfectious and parasitic diseasesMedicaidMedical tests and diagnostic methodsPrescription drugsState and local government operations

Quit Because of COVID-19 Act

USA116th CongressHR-7286| House 
| Updated: 6/22/2020
Quit Because of COVID-19 Act This bill provides for Medicaid and Children's Health Insurance Program (CHIP) coverage of certain tobacco cessation services during the public health emergency relating to COVID-19 (i.e., coronavirus disease 2019), as well as for two years after the emergency period ends. Specifically, the bill provides for coverage of diagnostic, therapy, and counseling services and pharmacotherapy, including prescription and nonprescription tobacco cessation agents, that are provided under medical supervision and in accordance with specified guidelines. The bill excludes such items and services from cost-sharing and applies an enhanced Federal Medical Assistance Percentage (i.e., federal matching rate).
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Jun 22, 2020
Introduced in House
Jun 22, 2020
Referred to the House Committee on Energy and Commerce.
Aug 12, 2020

Latest Companion Bill Action

S 116-4524
Introduced in Senate
  • June 22, 2020
    Introduced in House


  • June 22, 2020
    Referred to the House Committee on Energy and Commerce.


  • August 12, 2020

    Latest Companion Bill Action

    S 116-4524
    Introduced in Senate
Lisa Blunt Rochester

Lisa Blunt Rochester

Democratic Representative

Delaware

Cosponsors (41)
Kim Schrier (Democratic)Gilbert Ray Cisneros (Democratic)Stephanie N. Murphy (Democratic)Karen Bass (Democratic)Peter T. King (Republican)Darren Soto (Democratic)Derek Kilmer (Democratic)Eliot L. Engel (Democratic)Bobby L. Rush (Democratic)Steve Cohen (Democratic)Tony Cárdenas (Democratic)Paul Tonko (Democratic)Angie Craig (Democratic)Thomas R. Suozzi (Democratic)Wm. Lacy Clay (Democratic)Anthony G. Brown (Democratic)Lucille Roybal-Allard (Democratic)A. Donald McEachin (Democratic)Ann M. Kuster (Democratic)Joaquin Castro (Democratic)Mark DeSaulnier (Democratic)Harley Rouda (Democratic)Jahana Hayes (Democratic)Eleanor Holmes Norton (Democratic)Jamie Raskin (Democratic)Joe Neguse (Democratic)Diana DeGette (Democratic)Nydia M. Velázquez (Democratic)Yvette D. Clarke (Democratic)Brian K. Fitzpatrick (Republican)Bennie G. Thompson (Democratic)TJ Cox (Democratic)Nanette Diaz Barragán (Democratic)Donna E. Shalala (Democratic)Ayanna Pressley (Democratic)Alcee L. Hastings (Democratic)Debbie Wasserman Schultz (Democratic)Lauren Underwood (Democratic)Grace F. Napolitano (Democratic)Susan Wild (Democratic)Judy Chu (Democratic)

Energy and Commerce Committee

Health

Related Bills

  • S 116-4524: Quit Because of COVID–19 Act
  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Cardiovascular and respiratory healthChild healthDrug, alcohol, tobacco useDrug therapyEmergency medical services and trauma careHealth care costs and insuranceHealth care coverage and accessHealth promotion and preventive careInfectious and parasitic diseasesMedicaidMedical tests and diagnostic methodsPrescription drugsState and local government operations